(Q29006708)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24527034%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Vijaya Gadiyaram

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24527034%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Hannah Hazard

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24527034%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Barbara Ducatman

4

2 references

22 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24527034%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Gerald Hobbs

5

2 references

22 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24527034%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Sobha Kurian

7

2 references

22 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24527034%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Jame Abraham

8

2 references

22 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24527034%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

David P Rose

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24527034%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

1 reference

2014

1 reference

Journal of cancer epidemiology

22 March 2017

published in

3 references

22 March 2017

8 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24527034%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

2014

2 references

22 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24527034%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

170634

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24527034%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

5 June 2020

copyright license

start time

1 January 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

performing organization

West Virginia University

object named as

West Virginia University

1 reference

NIOSHTIC-2

on focus list of Wikimedia project

2 February 2024

Wikimedia–NIOSH collaboration

0 references

1 reference

25 September 2023

The epidemiology of triple-negative breast cancer, including race

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Risk factors for triple-negative breast cancer in women under the age of 45 years

23 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis

23 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Influence of obesity on breast cancer receptor status and prognosis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Angiogenesis, adipokines and breast cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Triple-negative breast cancer and obesity in a rural Appalachian population

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Prognostic effect of estrogen receptor status across age in primary breast cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Disparities in obesity rates: analysis by ZIP code area

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Triple-negative breast cancer: clinical features and patterns of recurrence

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

The significance of the site of recurrence to subsequent breast cancer survival.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Proliferation marker Ki-67 in early breast cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Obesity, Tamoxifen Use, and Outcomes in Women With Estrogen Receptor-Positive Early-Stage Breast Cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Bone metastases from breast carcinoma: histopathological - radiological correlations and prognostic features.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Socioeconomic factors and breast cancer in black and white Americans

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

The changing pattern of early breast cancer and its primary management at CAMC.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Progesterone receptors as a prognostic factor in Stage II breast cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

The "over-exposed" control group

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

3 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F170634

Pattern of metastatic spread in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F170634

Patterns of breast cancer relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F170634

Prognostic value of body mass index in locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F170634

Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F170634

Weight gain prior to diagnosis and survival from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F170634

The prognostic importance of triple negative breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F170634

Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F170634

State-specific prevalence of selected chronic disease-related characteristics--Behavioral Risk Factor Surveillance System, 2001

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Prognostic value of estrogen receptor status can be improved by combined evaluation of p53, Bcl2 and PgR expression: an immunohistochemical study on breast carcinoma with long-term follow-up

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913201

Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers

26 November 2018

1 reference

12 December 2020

The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer

1 reference

12 December 2020

Ethnicity and breast cancer: factors influencing differences in incidence and outcome

1 reference

12 December 2020

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

1 reference

12 December 2020

Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma

1 reference

12 December 2020

Estrogen receptors and distinct patterns of breast cancer relapse

1 reference

12 December 2020

Relation of body mass index (BMI) to disease free (DFS) and distant disease free survivals (DDFS) among Turkish women with operable breast carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1155/2014/170634

2 references

22 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24527034%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24527034%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

PubMed publication ID

24527034

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24527034%20AND%20SRC:MED&resulttype=core&format=json